Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6.

MLA

Tiedemann, Rodger E., et al. “Kinome-Wide RNAi Studies in Human Multiple Myeloma Identify Vulnerable Kinase Targets, Including a Lymphoid-Restricted Kinase, GRK6.” Blood, vol. 115, no. 8, Feb. 2010, pp. 1594–604. EBSCOhost, https://doi.org/10.1182/blood-2009-09-243980.

APA

Tiedemann, R. E., Zhu, Y. X., Schmidt, J., Yin, H., Shi, C.-X., Que, Q., Basu, G., Azorsa, D., Perkins, L. M., Braggio, E., Fonseca, R., Bergsagel, P. L., Mousses, S., & Stewart, A. K. (2010). Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. Blood, 115(8), 1594–1604. https://doi.org/10.1182/blood-2009-09-243980

Chicago

Tiedemann, Rodger E, Yuan Xiao Zhu, Jessica Schmidt, Hongwei Yin, Chang-Xin Shi, Qiang Que, Gargi Basu, et al. 2010. “Kinome-Wide RNAi Studies in Human Multiple Myeloma Identify Vulnerable Kinase Targets, Including a Lymphoid-Restricted Kinase, GRK6.” Blood 115 (8): 1594–1604. doi:10.1182/blood-2009-09-243980.